Manufacturing efficiency as a core cost lever
The guest argued that Moderna is obsessively focused on reducing manufacturing cycle time and physical footprint (square inches) to dramatically lower the cost of personalized cancer vaccines at scale.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.